[Summary] An innovative enterprise dedicated to the integration of research and
Chongqing Xinsaiya Biotechnology Co., Ltd. is located in the Shuitu High-tech Industrial Park, Liangjiang New Area, Chongqing. It is a production-oriented enterprise established in 2016 in Chongqing Liangjiang New Area by Kangnaide (Beijing) Biotechnology Co., Ltd., a high-tech enterprise in Zhongguancun, Beijing, focusing on the research and development, production, sales, and service of POCT reagents in the field of in vitro diagnostics. Our company has R&D centers in the United States, Beijing, and Chongqing, and has a technical team of PhDs and Masters with rich R&D experience. After years of research, we have made breakthrough progress in quantum dot POCT technology. Our quantum dot immunofluorescence analysis technology is at the leading level internationally.
At present, nearly 20 of our products have been successfully launched and sold. Our product lines are based on inflammation series, cardiac series, glycation items, and bone metabolism series, featuring maternal and child health series, especially vitamin D items, and with advantages in the world's first quantum dot methodology rapid detection of gastric function items (PG1/PG2+G17+gastric Helicobacter pylori typing HP), VEGF, and AMH items. The company has more than 80 projects under research and application, and the novel coronavirus (SARS-CoV-2) IgM/IgG antibody detection kit project has also been successfully developed. Xinsaiya, moving forward, will continue to enrich our product lines at a rate of more than 10 new projects launched each year. At present, our business not only covers the whole country but has also stepped out of the country, reaching strategic cooperation with multiple countries and regions.
Relying on advanced technological resources and an excellent team, Xinsaiya provides faster and more accurate detection methods to assist clinical formulation of effective treatment plans, improve patient treatment outcomes, improve people's quality of life, and reduce social medical costs. With the original intention that "talent is the core competitiveness of the enterprise", the company sincerely welcomes outstanding you to join all Xinsaiya people in dedicating passion, growing together, and moving toward a better tomorrow for Xinsaiya!
Award Information
July 2018 Selected as a "Chongqing Key Project of Technology Innovation and Application Demonstration"
October 2018 Awarded the title of "Chongqing New-type Enterprise R&D Institution"
December 2018 Rated as an outstanding enterprise in the "7th China Innovation and Entrepreneurship Competition Biomedical National Finals"
November 2019 Awarded "Chongqing 2019 High-tech Enterprise"
What does Chongqing Xinsaiya Biotechnology Co., Ltd. require? Who is Xinsaiya Biotechnology hiring? Xinsaiya Biotechnology recruitment: 销售类占比最多占33%,其次是经营管理类占18.2%. What education can get in at Xinsaiya Biotechnology? 大专占比最多占52.2%,其次是本科占40.2%. High education required at Xinsaiya Biotechnology? 硕士占1%. Work experience required at Xinsaiya Biotechnology? 3-5年占比最多占31.1%,其次是1-3年占27.3%. Where are the job locations at Xinsaiya Biotechnology? 重庆占比最多占72.7%,其次是广州占6.7%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows